Results 81 to 90 of about 136,109 (177)

Use of Sensors in the Treatment and Follow-up of Patients with Diabetes Mellitus

Sensors, 2010
Glucose control is the cornerstone of Diabetes Mellitus (DM) treatment. Although self-regulation using capillary glycemia (SRCG) still remains the best procedure in clinical practice, continuous glucose monitoring systems (CGM) offer the possibility of ...
Manuel Aguilar-Diosdado, Jose Ortego-Rojo, Manuel Cayon, Maria G. Baena, Isabel Torres   +4 more
doaj   +1 more source

Optimizing Asparaginase Treatment for Adolescent and Young Adult (AYA) Patients With Acute Lymphoblastic Leukemia: US Consensus Panel Recommendations

American Journal of Hematology, Volume 101, Issue 1, Page 41-55, January 2026.
ABSTRACT Asparaginase is an integral component of therapy for pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma. The success of asparaginase‐containing regimens has led to trials of pediatric/pediatric‐inspired regimens incorporating asparaginase for treating adolescent and young adult (AYA) and adult populations with acute ...
Ibrahim Aldoss, Amir Ali, Ryan D. Cassaday, Emily K. Curran, Marlise R. Luskin, Luke D. Maese, Etan Orgel, Dan Douer   +7 more
wiley   +1 more source

Glucose‐Lowering Properties of a Tea Formulation Containing Citrullus lanatus Peel, Ananas comosus Peel, and Mentha spicata L. Leaf Extracts in Dexamethasone‐Induced Insulin‐Resistant Wistar Rats

Food Science &Nutrition, Volume 14, Issue 1, January 2026.
The optimized tea blend exhibited high antioxidant activity and contained significant amounts of flavonoids, tannins, polyphenols, and vitamin C. In diabetic rats, the tea formulation significantly improved glycemic control, reduced lipid profiles, and enhanced liver and kidney function.
Irwin Leoda Begnone, Laurette Blandine Mezajoug Kenfack, Rosane Matsinkou Soh   +2 more
wiley   +1 more source

Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus

Diabetes, Metabolic Syndrome and Obesity, 2010
Pamela KushnerUniversity of California, Irvine College of Medicine, California, USAAbstract: Hypoglycemia is a major barrier to achieving glycemic goals in patients with diabetes.
Kushner P
doaj   +2 more sources

Glucose monitoring in the management of diabetes in pregnancy: A systematic review and meta‐analysis

Pregnancy, Volume 2, Issue 1, January 2026.
Abstract Background Diabetes in pregnancy (DIP: gestational, type 1 [T1D], and type 2 diabetes [T2D]) is increasing in global prevalence and was recently declared a public health priority by the World Health Organization (WHO). Aim This systematic review and meta‐analysis evaluated different glucose monitoring management for DIP, including routine care
Jessica Burk, Arianne Sweeting
wiley   +1 more source

Barriers and facilitators to insulin management in pregnant people with gestational diabetes mellitus: A qualitative study

Pregnancy, Volume 2, Issue 1, January 2026.
Abstract Objective To explore barriers and facilitators to gestational diabetes mellitus (GDM) self‐management and insulin use, aiming to inform future interventions, in a diverse population of pregnant people. Study design In this ancillary study of an ongoing randomized controlled trial testing thresholds for insulin initiation for GDM, participants ...
Idayat Akinola, Kathryn E. Flynn, Lynn M. Yee, Eleanor Saffian, Zaira Peterson, Anna Palatnik   +5 more
wiley   +1 more source

Safety and glycaemic control during exercise with the MiniMed™ 780G: A narrative review of evidence from lab to real world

Diabetes, Obesity and Metabolism, Volume 28, Issue S1, Page 49-60, January 2026.
Abstract Physical activity plays a critical role in reducing cardiovascular risk among individuals with type 1 diabetes (PwT1D); however, more than two‐thirds of PwT1D remain insufficiently active, primarily due to the unpredictability of glucose fluctuations and the fear of hypoglycaemia during exercise. Automated insulin delivery systems, such as the
Jeremy Basset‐Sagarminaga, Christophe De Block, Kirsten Nørgaard, David Norman O'Neal, Tim Van den Heuvel, Julie Taplin, Vittorino Smaniotto, Ohad Cohen   +7 more
wiley   +1 more source

Hypoglycemia incidence and awareness among insulin-treated patients with diabetes: the HAT study in Brazil

Diabetology & Metabolic Syndrome, 2018
Background Hypoglycemia affects patient safety and glycemic control during insulin treatment of both type 1 (T1DM) and type 2 diabetes mellitus (T2DM).
Rodrigo Nunes Lamounier, Bruno Geloneze, Silmara Oliveira Leite, Renan Montenegro, Lenita Zajdenverg, Milene Fernandes, Fabiano de Oliveira Griciunas, Mariana Narbot Ermetice, António Roberto Chacra, HAT Brazil study group   +9 more
doaj   +1 more source

Awareness of Vital Complications and Associated Factors Among Type 2 Diabetic Patients in Al‐Hudaydah, Yemen: A Cross‐Sectional Study

BioMed Research International, Volume 2026, Issue 1, 2026.
Background: Yemen ranks 120th in diabetes‐related mortality in 2020, with a mortality rate of 15.42 per 100,000 people. Awareness and early detection of diabetic complications are vital. Objective: This study is aimed at assessing the awareness of diabetes complications, specifically retinopathy, nephropathy, and hypoglycemia symptoms and associated ...
Khaled Alselwy, Mogeeb Saeed, Samuele Maramai   +2 more
wiley   +1 more source

From Pathophysiology to Treatment: Contemporary Approaches to CFRD in the Pediatric and Adolescent Population

Pediatric Diabetes, Volume 2026, Issue 1, 2026.
Cystic fibrosis‐related diabetes (CFRD) is the most prevalent nonrespiratory complication of cystic fibrosis (CF), with its prominence growing as survival rates improve due to advances in CFTR modulator therapies. Its prevalence increases with age, affecting nearly 50% of patients with CF (PwCF) over 30 years old.
Dogus Vuralli, Andrea Scaramuzza
wiley   +1 more source